DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...

In today’s fiercely competitive biotech industry, managing tight margins and evolving regulatory environments present major challenges. Add increased risks from geopolitical tensions, growing ...

Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.

Perth biotechs Avicena Systems and Syngenis Laboratories are fast-tracking pathogen detection technology to protect Australia’s health, trade and agriculture.

Two kernels, 100 years apart: One yielded 60 bushels per acre in 1927; the other topped 623. They look nearly identical on the outside, but a century of genetic innovation separates them under the ...

Funding by Melnichek Investments fuels Gero’s strategy to apply AI and real-world human health data to decode the relationship between aging and diseases, unravel their root causes, and create ...

Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...

Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...

MaxCyte granted Legend Biotech a non-exclusive worldwide license to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform in connection with the research, clinical development, and ...

3T Biosciences spun out of research I and my co-founder, Marvin Gee, did when we were at Stanford in Dr Christopher Garcia's lab. This work was focused on trying to identify targets of T-cell ...